Skip to content

HomeFitnessgarage

  • Beauty & Balance
  • Family Health
  • Kids Health
  • Health News
  • Health Problems
  • Medications
  • Personal Health

Home » Additional

Jazz Pharmaceuticals Announces FDA Approval of Additional Indication for Vyxeos (daunorubicin and cytarabine) for the Treatment of Secondary Acute Myeloid Leukemia in Pediatric Patients

03/31/2021 Medications

DUBLIN, March 30, 2021 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved a revised label for Vyxeos® (daunorubicin and cytarabine) to

Read more

Additional heart artery stenting reduces risk of future heart attacks

09/29/2019 Health Problems

Research has shown that patients who have had emergency heart attack treatment with heart artery stenting—and have significant narrowings in their other untreated arteries—can benefit

Read more
Personal Health
Why It's Not a Bad Thing If You Don't Experience COVID-19 Vaccine Side Effects

An Indie Artist’s Plea to Look Beyond Algorithms and Curated Playlists

Model Winnie Harlow Rocks a String Bikini in New Instagram Pictures-And She Looks Confident AF

Health News
More COVID state shutdowns unlikely, despite CDC suggestion

New study explains why you should look at your food before casting judgment

Medications
Jazz Pharmaceuticals Announces FDA Approval of Additional Indication for Vyxeos (daunorubicin and cytarabine) for the Treatment of Secondary Acute Myeloid Leukemia in Pediatric Patients

KHN’s ‘What the Health?’: All About Budget Reconciliation

KHN’s ‘What the Health?’: Covid and Kids

Copyright © 2021